Detalhe da pesquisa
1.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046348
2.
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Breast Cancer Res
; 24(1): 61, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096872
3.
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Breast Cancer Res Treat
; 190(2): 295-305, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524591
4.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol
; 21(11): 1443-1454, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152284
5.
Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study.
Br J Cancer
; 123(1): 17-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362658
6.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892336
7.
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
Breast Cancer Res
; 18(1): 39, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036195
8.
Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.
Breast Cancer Res Treat
; 151(1): 121-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25850535
9.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Lancet Oncol
; 15(2): 201-12, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24360787
10.
Optimum duration of neoadjuvant letrozole to permit breast conserving surgery.
Breast Cancer Res Treat
; 144(3): 569-76, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562823
11.
Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMI.
Cancer Med
; 12(5): 5506-5516, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507561
12.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
EBioMedicine
; 83: 104205, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985932
13.
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.
Clin Cancer Res
; 28(7): 1323-1334, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165099
14.
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).
Breast Cancer Res
; 12(6): R92, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21059212
15.
Unusual case of initial failure of pacemaker implantation.
Europace
; 12(11): 1651-2, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622255
16.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Nat Commun
; 11(1): 2662, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471999
17.
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT).
Clin Cancer Res
; 26(7): 1574-1585, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836609
18.
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Breast Cancer Res Treat
; 117(1): 91-8, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19112615
19.
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
NPJ Breast Cancer
; 5: 42, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754627
20.
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
JAMA Oncol
; 5(10): 1473-1478, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369045